A detailed history of Jane Street Group, LLC transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 13,761 shares of VOR stock, worth $11,972. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,761
Previous 222,501 93.82%
Holding current value
$11,972
Previous $222,000 95.95%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.7 - $1.1 $146,118 - $229,614
-208,740 Reduced 93.82%
13,761 $9,000
Q2 2024

Aug 14, 2024

BUY
$1.0 - $2.2 $203,009 - $446,619
203,009 Added 1041.5%
222,501 $222,000
Q1 2024

May 15, 2024

BUY
$1.8 - $2.85 $4,584 - $7,258
2,547 Added 15.03%
19,492 $46,000
Q4 2023

Feb 14, 2024

BUY
$1.66 - $2.63 $28,128 - $44,565
16,945 New
16,945 $38,000
Q2 2023

Aug 14, 2023

SELL
$3.09 - $5.33 $113,285 - $195,408
-36,662 Reduced 28.39%
92,462 $285,000
Q1 2023

May 15, 2023

BUY
$4.68 - $6.96 $284,178 - $422,625
60,722 Added 88.77%
129,124 $694,000
Q4 2022

Feb 14, 2023

BUY
$3.77 - $7.43 $218,622 - $430,865
57,990 Added 556.95%
68,402 $454,000
Q3 2022

Nov 14, 2022

BUY
$3.9 - $5.52 $40,606 - $57,474
10,412 New
10,412 $41,000

Others Institutions Holding VOR

About Vor Biopharma Inc.


  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $33.1M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.